{
  "catalogId": "da119473-23f5-4e5d-92cd-647fc67e1035",
  "name": "OPSUMIT ®",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "152 72 34061 01",
  "treatmentDescriptions": "Opsumit ® is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression. Disease progression included: death, initiation of intravenous (IV) or subcutaneous prostanoids or clinical worsening of PAH (decreased 6-minute walk distance, worsened PAH symptoms and need for additional PAH treatment). Opsumit also reduced hospitalization for PAH.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "MACITENTAN",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "C02KX04",
      "name": "MACITENTAN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "OPSUMIT 10MG 30 F.C.TAB",
      "manufacturer": {
        "name": "יאנסן סילג",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/PE/PVDC/AL",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7664",
        "yarpa": "68449",
        "pharmasoft": "15446"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 7665.925229,
        "retailMargin": 10.0,
        "maxRetailPrice": 8432.517751,
        "maxPriceWithVAT": 9950.370504
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.232603"
  }
}